Authored By: Sarah
03 Feb 2025

Proteomics Market Poised for Expansion with Advancements in Protein Analysis Technologies (2025-2029)

The Proteomics Market is projected to experience substantial growth, increasing by USD 40.78 billion at a CAGR of 17.6% from 2024 to 2029. Proteomics, a branch of molecular biology focused on large-scale protein analysis, plays a crucial role in identifying biomarkers, therapeutic targets, and drug development, transforming healthcare and biotechnology sectors. Key drivers fueling this market expansion include technological advancements, increased funding for proteomics research, and the rising demand for personalized medicine. However, the industry faces challenges such as a shortage of skilled laboratory professionals, which may impede growth. To overcome these hurdles, collaborations between academia and industry, alongside the development of automated solutions, are gaining importance.

Global Proteomics Market 2025-2029

For more details about the industry, get the PDF sample report for free

Market Dynamics: Drivers, Trends, and Challenges

  • Key Drivers: One of the major drivers of the proteomics market is the continuous advancements in proteomics technology, which enable more efficient analysis of proteins and their functions. The integration of proteomics with other omics technologies, like genomics and metabolomics, is expected to create new opportunities in the field. Furthermore, the growing focus on personalized medicine and early disease diagnosis is fueling demand for proteomics services and products.

  • Emerging Trends: A prominent trend in proteomics research is the increasing focus on monitoring post-translational modifications (PTMs) of proteins, which are critical for understanding disease mechanisms, including genetic and birth disorders. Additionally, protein-protein interactions, network mapping, and kinetics studies are crucial to uncovering disease biomarkers and therapeutic targets.

  • Challenges: The proteomics market faces challenges like the shortage of trained laboratory professionals and the need for improved scalability and reproducibility in proteomics technologies. Moreover, complex data integration and analysis remain a significant hurdle, requiring advancements in informatics tools.

Regional Market

  • North America: North America is anticipated to contribute 39% to the growth of the global proteomics market during the forecast period. The region benefits from a robust biotechnology industry, significant funding for research, and a high prevalence of chronic diseases. Key applications in the region include drug discovery and clinical diagnostics. The use of advanced technologies like Mass Spectroscopy, X-ray Crystallography, Protein Fractionation, and Electrophoresis is expected to drive market growth.

    • Key Countries in North America:
      • United States
      • Canada
  • Europe: Europe is expected to be a major player in the proteomics market, with significant advancements in biotechnology and healthcare research. The increasing prevalence of genetic disorders and the demand for personalized medicine contribute to the region's market expansion.

    • Key Countries in Europe:
      • Germany
      • United Kingdom
      • France
      • Italy
  • Asia-Pacific: The Asia-Pacific region is likely to see substantial growth due to increasing investments in healthcare infrastructure, rising awareness of proteomics applications in drug development, and expanding research capabilities in countries like China, India, Japan, and South Korea.

    • Key Countries in Asia:
      • China
      • India
      • Japan
      • South Korea
  • Rest of the World (ROW): The proteomics market is also expanding in regions beyond the major markets, driven by advancements in research and healthcare initiatives. The ROW market is expected to benefit from global trends in biotechnology and diagnostics.

Segmentation by Product

The proteomics market is segmented into reagents, instruments, and services. Among these, the reagents segment is poised to witness the highest growth during the forecast period. Proteomics reagents, such as antibodies, buffers, enzymes, and kits, are essential for protein detection, isolation, and quantification. The increasing use of robotics and automation in proteomics research enhances the efficiency and accuracy of these reagents.

  • Reagents: Estimated to experience significant growth due to the rising demand for protein quantification and isolation.
  • Instruments: Critical in the analysis and characterization of proteins, including mass spectrometers and protein microarrays.
  • Services: Services related to clinical diagnostics, drug discovery, and other proteomics applications are becoming integral to the market.

End-user Segmentation

Proteomics applications span across various industries, including clinical diagnostics, drug discovery, and other sectors. The growing focus on precision medicine and early disease diagnosis is contributing to the increasing demand for proteomics services in clinical diagnostics and drug discovery.

  • Clinical Diagnostics: Proteomics technologies are used to identify biomarkers associated with diseases, enabling early and accurate diagnosis.
  • Drug Discovery: Proteomics plays a pivotal role in drug development, particularly in identifying therapeutic targets and biomarkers for specific diseases.

Get more details by ordering the complete report

Key Companies in the Proteomics Market

Some of the key companies of the Proteomics Market are as follows:

  • Agilent Technologies Inc.
  • Applied Biomics Inc.
  • Bio Rad Laboratories Inc.
  • Biognosys AG
  • Bruker Corp.
  • Cell Signaling Technology Inc.
  • CellCarta Biosciences Inc.
  • Creative Proteomics
  • DiaSorin Spa
  • F. Hoffmann La Roche Ltd.
  • Geno Technology Inc.
  • HORIBA Ltd.
  • Illumina Inc.
  • Olink Holding AB
  • Perkin Elmer Inc.
  • Promega Corp.
  • QIAGEN N.V.
  • Sigma Aldrich Chemicals Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
  • Waters Corp.

Recent Developments:

  • December 2024: Thermo Fisher Scientific launched an advanced proteomics platform utilizing mass spectrometry technology to enhance the sensitivity and throughput of protein analysis. This development aims to support drug discovery and biomarker identification.
  • November 2024: Agilent Technologies introduced a new proteomics solution integrating artificial intelligence with liquid chromatography-mass spectrometry (LC-MS) systems, streamlining the analysis of complex protein mixtures.
  • October 2024: Bio-Rad Laboratories unveiled a new proteomics kit designed for faster and more accurate protein quantification, specifically aimed at clinical research applications.
  • September 2024: Waters Corporation partnered with a leading pharmaceutical company to integrate advanced proteomics technology into drug development processes, particularly for personalized medicine.
Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.